Impact BioMedical (IBO) Q2 2026 Earnings

Screener

Reported August 7, 2026 · Before market open

Revenue$3.0K

EPS-$0.01

Next report

Date not yet announced

Versus estimates

Revenue

Q2 2026$3.0K

Q1 2026$7.0K Q4 2025$7.0K Q3 2025$18.0K Q2 2025$5.1K

Diluted EPS

Q2 2026-$0.01

Q1 2026-$0.02 Q4 2025-$0.42 Q3 2025-$0.12 Q2 2025-$1.18 Q1 2025-$0.11

FAQ

When did Impact BioMedical report Q2 2026 earnings?: Impact BioMedical (IBO) reported Q2 2026 earnings on August 7, 2026 before market open.
What were Impact BioMedical's Q2 2026 revenue and EPS?: Impact BioMedical reported revenue of $3.0K and eps of $-0.01 for Q2 2026.
How did Impact BioMedical's Q2 2026 results compare year-over-year?: Compared to the same quarter a year prior, revenue declined 41.4% from $5.1K a year earlier and eps grew 99.2% from $-1.18.
Where can I find Impact BioMedical's Q2 2026 SEC filings?: You can read the 10-Q periodic report (0001493152-26-036601) directly on SEC EDGAR. The filing index links above go to sec.gov.

Ask the moment Impact BioMedical reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk